Shree Pacetronix Ltd.
Snapshot View

18.94 +0.90 ▲5.0%

26 July 2021, 04:00:00 P.M.
Volume: 500

Overview View Details

Sector Healthcare Compare with Sector peers
Industry Medical Equipment/Supplies/Accessories Compare with Industry peers
Website http://www.pacetronix.com
Financial Indicators
Market Cap 6.63 Cr.
Earnings per share (EPS) 0.14 Trailing Twelve Months Ending 2021-03
Price-Earning Ratio (PE) 125.04 Trailing Twelve Months Ending 2021-03
Industry PE - Trailing Twelve Months Ending 2021-03
Book Value / Share 15.54 Trailing Twelve Months Ending 2021-03
Price to Book Value 1.16 Calculated using Price: 18.04
Dividend Yield 0.00 Period Ending 2020-03
No. of Shares Subscribed 0.37 Cr. 3,673,600 Shares
FaceValue 10
Company Profile

Shree Pacetronix was incorporated on January 11, 1988 as a Pvt. Ltd. company. In 1993 the company was converted to a Public Limited Company. The company is listed on Bombay Stock Exchange and regional exchanges and has strength of about 7000 shareholders today.

Shree Pacetronix India’s pioneer Pacemaker project, in technical collaboration with companies in USA to produce Pacemakers and other related products of International quality at an affordable price

Product range of the company includes:

  • Pacemakers
  • Leads
  • Pacing System Analyzer
  • Titanium Dental Implants
  • Mobile X-Ray Machine

Achievements/ recognition:

  • EC Certificate
  • ISO Certificate.

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
+4.99%
1 Week
+21.33%
1 Month
+96.68%
3 Month
+63.70%
6 Month
+79.53%
1 Year
+57.18%
2 Year
+47.28%
5 Year
+24.61%
9 years 2012-03 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03
Return on Equity (%) 0.03 3.31 4.29 -1.11 -1.61 -6.34 2.61 2.68 4.34
Return on Capital Employed (%) 5.92 8.71 10.61 3.82 4.18 -0.64 6.51 6.63 8.05
Return on Assets (%) 0.02 1.86 2.52 -0.67 -0.97 -3.79 1.48 1.43 2.23

Balance Sheet View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Shh. Funds 5 5 5 5 5 5 5 5 6
Non Curr. Liab. 1 0 0 0 0 0 1 1 0
Curr. Liab. 3 4 3 3 3 3 3 4 5
Minority Int.
Equity & Liab. 9 9 9 9 9 9 9 10 11
Non Curr. Assets 4 4 4 3 3 3 3 4 4
Curr. Assets 5 5 5 6 6 6 6 7 6
Misc. Exp. not W/O
Total Assets 9 9 9 9 9 9 9 10 11

Profit Loss View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Net Sales 7 7 8 7 7 7 7 7 9
Other Income 0 0 0 0 0 0 0 0 0
Total Income 7 7 8 7 7 7 7 7 9
Total Expenditure -6 -6 -7 -6 -6 -6 -6 -7 -8
PBIDT 1 1 1 1 1 1 1 1 1
Interest 0 0 0 0 0 0 0 0 0
Depreciation -1 -1 -1 -1 -1 -1 0 0 -1
Taxation 0 0 0 0 0 0 0 0 0
Exceptional Items
PAT 0 0 0 0 0 0 0 0

Cash Flow View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Cash Fr. Operatn. 0 1 1 0 1 0 1 0 2
Cash Fr. Inv. 0 0 0 0 0 -1 -1 -1 -1
Cash Fr. Finan. -1 -1 -1 0 -1 0 -1 0 -1
Net Change 0 0 0 0 0 0 0 0 0
Cash & Cash Eqvt 1 0 0 0 0 0 0 0 1

Shareholding Pattern View Details

9 Qtrs 2019-06 (%) 2019-09 (%) 2019-12 (%) 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%)
Promoter 24.25 24.25 24.25 24.25 24.25 24.25 24.25 24.25 24.25
Public 75.75 75.75 75.75 75.75 75.75 75.75 75.75 75.75 75.75
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details

Mon, 12 Jul 2021
Shareholding for the Period Ended June 30 2021
Shree Pacetronix Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30 2021. For more details kindly Click here
Mon, 05 Jul 2021
Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter
0110
Name of the Signatory :- Harshita Jindal
Designation :- Company Secretary and Compliance Officer
Wed, 30 Jun 2021
Submission Of Audited Financial Results (Standalone And Consolidated) Along With Audit Report For The Quarter And Financial Year Ended 31St March 2021
Pursuant to Regulation 30 & 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed herewith the following:
1.Audited Financial Results (Standalone and Consolidated) for the Quarter and Financial Year ended 31st March 2021.
2.Audit Report on the Financial Results (Standalone and Consolidated) for the Quarter and Financial Year ended 31st March 2021.
The aforesaid results are duly approved by the Audit Committee and Board of Directors in their respective meetings held on Wednesday 30th June 2021.

Technical Scans View Details

Fri, 23 Jul 2021
Stock Outperforming Benchmark Index in both 1 Week and 3 Month Stock Outperforming Benchmark Index in both 1 Week and 3 Month
Stock Outperforming Sectoral Index in both 1 Week and 3 Month Stock Outperforming Sectoral Index in both 1 Week and 3 Month
Strongly Outperforming Benchmark Index Strongly Outperforming Benchmark Index
Strongly Outperforming Sectoral Index Strongly Outperforming Sectoral Index
Close Crossing 2 Year High Close Crossing 2 Year High

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 166,513.85 703.40 +1.4%
Divi's Laboratories Ltd. 128,088.59 4,910.15 +1.8%
Dr. Reddy's Laboratories Ltd. 90,175.51 5,411.25 -0.2%
Cipla Ltd. 76,510.04 950.55 +0.3%
Cadila Healthcare Ltd. 62,965.29 605.55 -1.6%
Aurobindo Pharma Ltd. 56,484.48 952.95 -1.1%
Apollo Hospitals Enterprise Ltd. 56,291.69 4,100.95 +4.7%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 57.34 703.40 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 64.55 4,910.15 +1.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 46.21 5,411.25 -0.2%
Cipla Ltd. Consolidated 2021-03 31.81 950.55 +0.3%
Cadila Healthcare Ltd. Consolidated 2021-03 29.51 605.55 -1.6%
Aurobindo Pharma Ltd. Consolidated 2021-03 10.59 952.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 374.38 4,100.95 +4.7%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 3.58 703.40 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 13.78 4,910.15 +1.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 5.15 5,411.25 -0.2%
Cipla Ltd. Consolidated 2021-03 4.17 950.55 +0.3%
Cadila Healthcare Ltd. Consolidated 2021-03 4.85 605.55 -1.6%
Aurobindo Pharma Ltd. Consolidated 2021-03 2.58 952.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 12.25 4,100.95 +4.7%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 0.18 703.40 +1.4%
Divi's Laboratories Ltd. Consolidated 2020-03 0.00 4,910.15 +1.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 0.17 5,411.25 -0.2%
Cipla Ltd. Consolidated 2020-03 0.18 950.55 +0.3%
Cadila Healthcare Ltd. Consolidated 2021-03 0.35 605.55 -1.6%
Aurobindo Pharma Ltd. Consolidated 2020-03 0.33 952.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 1.08 4,100.95 +4.7%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 9.66 703.40 +1.4%
Divi's Laboratories Ltd. Consolidated 2020-03 19.30 4,910.15 +1.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 5,411.25 -0.2%
Cipla Ltd. Consolidated 2020-03 10.09 950.55 +0.3%
Cadila Healthcare Ltd. Consolidated 2021-03 18.30 605.55 -1.6%
Aurobindo Pharma Ltd. Consolidated 2020-03 18.53 952.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 13.08 4,100.95 +4.7%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 10.07 703.40 +1.4%
Divi's Laboratories Ltd. Consolidated 2020-03 25.36 4,910.15 +1.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 15.24 5,411.25 -0.2%
Cipla Ltd. Consolidated 2020-03 12.53 950.55 +0.3%
Cadila Healthcare Ltd. Consolidated 2021-03 13.65 605.55 -1.6%
Aurobindo Pharma Ltd. Consolidated 2020-03 18.80 952.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 17.13 4,100.95 +4.7%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 32,837.50 703.40 +1.4%
Divi's Laboratories Ltd. Consolidated 2020-03 5,394.42 4,910.15 +1.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 19,047.50 5,411.25 -0.2%
Cipla Ltd. Consolidated 2020-03 17,131.99 950.55 +0.3%
Cadila Healthcare Ltd. Consolidated 2021-03 15,102.20 605.55 -1.6%
Aurobindo Pharma Ltd. Consolidated 2020-03 23,098.51 952.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 11,246.80 4,100.95 +4.7%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 4,186.79 703.40 +1.4%
Divi's Laboratories Ltd. Consolidated 2020-03 1,376.54 4,910.15 +1.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 1,903.60 5,411.25 -0.2%
Cipla Ltd. Consolidated 2020-03 1,546.98 950.55 +0.3%
Cadila Healthcare Ltd. Consolidated 2021-03 2,137.60 605.55 -1.6%
Aurobindo Pharma Ltd. Consolidated 2020-03 2,844.69 952.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 434.90 4,100.95 +4.7%